Adding encorafenib (Braftovi) and cetuximab (Erbitux) to FOLFIRI chemotherapy significantly improved progression-free ...

A targeted treatment that triggers the death of cancer cells has shown promise for patients with advanced bowel cancer when ...

Talazoparib plus enzalutamide reduces progression risk by 50% in men with DNA repair alter ...

A new study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center shows that the targeted cancer ...

New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.

A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of ...

The field is ecstatic about the prospect of a targeted therapy meaningfully extending overall survival in pancreatic cancer.

The targeted therapy sunvozertinib was more effective than standard platinum-based chemotherapy as a first-line treatment for ...

The drug daraxonrasib nearly doubled the overall survival rates of pancreatic cancer patients. Here's how it works and who ...

Dedifferentiated liposarcoma (DDLS) is a rare and aggressive soft tissue cancer with few effective treatment options. But now ...

Keaton Herzer tells PEOPLE a newer targeted therapy unexpectedly shrank his tumors enough to qualify for a liver transplant ...